RVMD
Revolution Medicines, Inc. Common Stock
stockNASDAQ
revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 201.74 | 2026-09-28 | +2.43% | -0.552 |
| 1M | 210.02 | 2026-09-04 | -1.60% | 1.148 |
| 3M | 189.99 | 2026-07-06 | +8.77% | 0.789 |
| 6M | 95.36 | 2026-04-06 | +116.70% | 1.337 |
| 1Y | 46.71 | 2025-10-03 | +342.41% | 1.104 |
| 2Y | 47.32 | 2024-10-04 | +336.71% | — |
| 5Y | 28.60 | 2021-10-04 | +622.55% | 1.294 |
Revolution Medicines, Inc. Common Stock (NASDAQ:RVMD) stock price today is $206.65, and today's volume is 1,570,495. RVMD is up 0.369% today. The 30 day average volume is 2.07M. RVMD market cap is $44.29B with 214.34M shares outstanding.